{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:08:43Z","timestamp":1775488123193,"version":"3.50.1"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"abstract":"<jats:p>Valvular heart disease (VHD) is a common cardiovascular disorder with insidious early symptoms and can progress to heart failure or sudden death. Pharmacological options remain limited, and severe disease often requires surgical intervention. This study aimed to identify key molecular targets and potential therapeutic candidates for VHD using Mendelian randomization (MR) and integrative analyses. A 2-sample MR design was used to evaluate the association between genetically predicted exposures and VHD using publicly available genome-wide association study summary statistics. Downstream analyses included functional enrichment, drug repurposing with molecular docking, protein\u2013protein interaction network construction with hub-gene identification, and single-cell RNA sequencing-based analysis to examine the cell-type distribution of candidate gene expression. MR analysis identified 76 genes associated with VHD, including stathmin 1, ribosomal protein S5, and mitogen-activated protein kinase 8. Enrichment analysis suggested that these genes were involved in multiple signaling pathways potentially related to disease progression. Drug prediction and molecular docking prioritized razoxane, reserpine, and bisindolylmaleimide I as candidate compounds targeting key molecules. Protein\u2013protein interaction network analysis further identified 10 hub genes, such as DEAD-box helicase 6 and apolipoprotein E. Single-cell sequencing showed high expression of these genes in cardiomyocytes, fibroblasts, and smooth muscle cells. This study identified candidate genes and potential drug leads for VHD through an MR-based integrative analysis, providing targets for subsequent mechanistic and experimental validation.<\/jats:p>","DOI":"10.1097\/md.0000000000048210","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:00:48Z","timestamp":1775232048000},"page":"e48210","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["New perspectives on the mechanisms and treatment of valvular heart disease: Mendelian randomization and systematic analysis based on plasma proteins"],"prefix":"10.1097","volume":"105","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moxuan","family":"Han","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Feng","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hezeng","family":"Dong","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Integrated Traditional Chinese and Western Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqian","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0924-1233","authenticated-orcid":false,"given":"Yue","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260406","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College Of Cardiology\/American Heart Association joint committee on clinical practice guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"R2-20260406","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/jcm12062178","article-title":"The global burden of valvular heart disease: from clinical epidemiology to management.","volume":"12","author":"Santangelo","year":"2023","journal-title":"J Clin Med"},{"key":"R3-20260406","first-page":"32","article-title":"Valvular heart disease epidemiology.","volume":"10","author":"Aluru","year":"2022","journal-title":"Med Sci (Basel)"},{"key":"R4-20260406","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","article-title":"Global epidemiology of valvular heart disease.","volume":"18","author":"Coffey","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R5-20260406","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12872-016-0184-8","article-title":"The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.","volume":"16","author":"Rezzoug","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"R6-20260406","doi-asserted-by":"crossref","first-page":"e002039","DOI":"10.1136\/openhrt-2022-002039","article-title":"Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.","volume":"9","author":"Tung","year":"2022","journal-title":"Open Heart"},{"key":"R7-20260406","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s40520-025-02937-5","article-title":"The PREVASC study: prospective REgistry of valve disease in asymptomatic Italian elderly SubjeCts.","volume":"37","author":"Carrabba","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"R8-20260406","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11886-024-02041-6","article-title":"Insights into the inherited basis of valvular heart disease.","volume":"26","author":"Yu","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"R9-20260406","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(23)02755-1","article-title":"Valvular heart disease: from mechanisms to management.","volume":"403","author":"Praz","year":"2024","journal-title":"Lancet"},{"key":"R10-20260406","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jacc.2025.06.049","article-title":"The pathophysiologic basis and management of calcific aortic valve stenosis: JACC state-of-the-art review.","volume":"86","author":"Desai","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260406","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.119.041080","article-title":"Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart disease II survey.","volume":"140","author":"Iung","year":"2019","journal-title":"Circulation"},{"key":"R12-20260406","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3892\/etm.2016.3048","article-title":"Pathophysiology of valvular heart disease.","volume":"11","author":"Zeng","year":"2016","journal-title":"Exp Ther Med"},{"key":"R13-20260406","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1161\/CIR.0000000000001254","article-title":"Unraveling the mechanisms of valvular heart disease to identify medical therapy targets: a scientific statement from the American Heart Association.","volume":"150","author":"Small","year":"2024","journal-title":"Circulation"},{"key":"R14-20260406","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.21037\/jtd-20-1669","article-title":"Novel insights into the molecular basis of calcific aortic valve disease.","volume":"12","author":"Rys\u00e4","year":"2020","journal-title":"J Thorac Dis"},{"key":"R15-20260406","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2023.11.021","article-title":"Large-scale proteomics identifies novel biomarkers and circulating risk factors for aortic stenosis.","volume":"83","author":"Shelbaya","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R16-20260406","doi-asserted-by":"crossref","first-page":"e36336","DOI":"10.1161\/JAHA.124.036336","article-title":"Plasma proteomic assessment of calcific aortic valve disease in older adults.","volume":"14","author":"Bortnick","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"R17-20260406","first-page":"432","article-title":"Research progress on pharmacotherapy of calcific aortic valve disease.","volume":"45","author":"Du","year":"2016","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"R18-20260406","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","article-title":"Large-scale plasma proteomics comparisons through genetics and disease associations.","volume":"622","author":"Eldjarn","year":"2023","journal-title":"Nature"},{"key":"R19-20260406","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease.","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"R20-20260406","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/s41467-022-33675-1","article-title":"Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"R21-20260406","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat Genet"},{"key":"R22-20260406","article-title":"The MRC IEU OpenGWAS data infrastructure.","author":"Elsworth","year":"2020","journal-title":"bioRxiv"},{"key":"R24-20260406","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization.","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"R26-20260406","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis.","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"},{"key":"R27-20260406","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting.","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"R28-20260406","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R29-20260406","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R31-20260406","doi-asserted-by":"crossref","first-page":"baz046","DOI":"10.1093\/database\/baz046","article-title":"PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data.","volume":"2019","author":"Franz\u00e9n","year":"2019","journal-title":"Database (Oxford)"},{"key":"R32-20260406","first-page":"2579","article-title":"Visualizing data using t-SNE.","volume":"9","author":"Van der Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"key":"R33-20260406","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1021\/acs.jproteome.1c00657","article-title":"Advances and utility of the human plasma proteome.","volume":"20","author":"Deutsch","year":"2021","journal-title":"J Proteome Res"},{"key":"R34-20260406","doi-asserted-by":"crossref","first-page":"942","DOI":"10.15252\/msb.20156297","article-title":"Revisiting biomarker discovery by plasma proteomics.","volume":"13","author":"Geyer","year":"2017","journal-title":"Mol Syst Biol"},{"key":"R35-20260406","doi-asserted-by":"crossref","first-page":"1457506","DOI":"10.3389\/fcell.2024.1457506","article-title":"Polarity and migration of cranial and cardiac neural crest cells: underlying molecular mechanisms and disease implications.","volume":"12","author":"Salinas","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"R36-20260406","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3892\/mmr.2016.4755","article-title":"Netrin-1 prevents the development of cardiac hypertrophy and heart failure.","volume":"13","author":"Wang","year":"2016","journal-title":"Mol Med Rep"},{"key":"R37-20260406","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41467-024-54908-5","article-title":"Small-molecule-induced ERBB4 activation to treat heart failure.","volume":"16","author":"Cools","year":"2025","journal-title":"Nat Commun"},{"key":"R38-20260406","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.semcdb.2010.09.011","article-title":"ErbB signaling in cardiac development and disease.","volume":"21","author":"Sanchez-Soria","year":"2010","journal-title":"Semin Cell Dev Biol"},{"key":"R39-20260406","doi-asserted-by":"crossref","first-page":"738325","DOI":"10.3389\/fcvm.2021.738325","article-title":"The role of the VEGF family in coronary heart disease.","volume":"8","author":"Zhou","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R40-20260406","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/biomedicines12051055","article-title":"Vascular endothelial growth factor (VEGF) and its role in the cardiovascular system.","volume":"12","author":"Florek","year":"2024","journal-title":"Biomedicines"},{"key":"R41-20260406","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.18632\/aging.202332","article-title":"Dexrazoxane ameliorates radiation-induced heart disease in a rat model.","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R42-20260406","doi-asserted-by":"crossref","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis.","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"R43-20260406","doi-asserted-by":"crossref","first-page":"1092148","DOI":"10.3389\/fphar.2023.1092148","article-title":"Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: focus on the TGF-\u03b2\/Smad signaling pathway.","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"R44-20260406","doi-asserted-by":"crossref","first-page":"e8209","DOI":"10.1161\/CIRCHEARTFAILURE.120.008209","article-title":"Clinically translatable prevention of anthracycline cardiotoxicity by dexrazoxane is mediated by topoisomerase II beta and not metal chelation.","volume":"14","author":"Jirkovsk\u00fd","year":"2021","journal-title":"Circ Heart Fail"},{"key":"R45-20260406","doi-asserted-by":"crossref","first-page":"111384","DOI":"10.1016\/j.cbi.2025.111384","article-title":"Antifibrotic potential of reserpine (alkaloid) targeting Keap1\/Nrf2; oxidative stress pathway in CCl(4)-induced liver fibrosis.","volume":"407","author":"Sohail","year":"2025","journal-title":"Chem Biol Interact"},{"key":"R46-20260406","doi-asserted-by":"crossref","first-page":"1260912","DOI":"10.3389\/fmmed.2023.1260912","article-title":"Editorial: heart valve diseases: from molecular mechanisms to clinical implications.","volume":"3","author":"Ibarrola","year":"2023","journal-title":"Front Mol Med"},{"key":"R47-20260406","doi-asserted-by":"crossref","first-page":"774573","DOI":"10.3389\/fcvm.2022.774573","article-title":"Serotonin\u2014a driver of progressive heart valve disease.","volume":"9","author":"Waldum","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R48-20260406","doi-asserted-by":"crossref","first-page":"eadc9606","DOI":"10.1126\/scitranslmed.adc9606","article-title":"Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation.","volume":"15","author":"Castillero","year":"2023","journal-title":"Sci Transl Med"},{"key":"R49-20260406","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/pharmaceutics12111110","article-title":"Formulation of liver-specific PLGA-DY-635 nanoparticles loaded with the protein kinase C inhibitor bisindolylmaleimide I.","volume":"12","author":"Shkodra","year":"2020","journal-title":"Pharmaceutics"},{"key":"R50-20260406","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.apha.2016.06.002","article-title":"Protein kinase C as regulator of vascular smooth muscle function and potential target in vascular disorders.","volume":"78","author":"Ringvold","year":"2017","journal-title":"Adv Pharmacol"},{"key":"R51-20260406","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yjmcc.2019.01.029","article-title":"PKC and PKN in heart disease.","volume":"128","author":"Marrocco","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"R52-20260406","doi-asserted-by":"crossref","first-page":"e1009967","DOI":"10.1371\/journal.pgen.1009967","article-title":"The RNA helicase DDX6 controls early mouse embryogenesis by repressing aberrant inhibition of BMP signaling through miRNA-mediated gene silencing.","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS Genet"},{"key":"R53-20260406","doi-asserted-by":"crossref","first-page":"12476","DOI":"10.1111\/jcmm.15779","article-title":"Celastrol attenuates arterial and valvular calcification via inhibiting BMP2\/Smad1\/5 signalling.","volume":"24","author":"Su","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R54-20260406","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajhg.2019.07.010","article-title":"Rare de novo missense variants in RNA helicase DDX6 cause intellectual disability and dysmorphic features and lead to p-body defects and RNA dysregulation.","volume":"105","author":"Balak","year":"2019","journal-title":"Am J Hum Genet"},{"key":"R55-20260406","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrc.2021.03.066","article-title":"DDX6 is a positive regulator of Ataxin-2\/PAPD4 cytoplasmic polyadenylation machinery.","volume":"553","author":"Inagaki","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"R56-20260406","doi-asserted-by":"crossref","first-page":"682859","DOI":"10.3389\/fonc.2021.682859","article-title":"HNRNPH1 Is a novel regulator of cellular proliferation and disease progression in chronic myeloid leukemia.","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"R57-20260406","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/ATVBAHA.123.319925","article-title":"RNA-binding proteins regulate post-transcriptional responses to TGF-\u03b2 to coordinate function and mesenchymal activation of murine endothelial cells.","volume":"43","author":"Wardman","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R58-20260406","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1172\/JCI95442","article-title":"Mutations in the netrin-1 gene cause congenital mirror movements.","volume":"127","author":"M\u00e9neret","year":"2017","journal-title":"J Clin Invest"},{"key":"R59-20260406","first-page":"405469526","article-title":"Netrin-1: focus on its role in cardiovascular physiology and atherosclerosis.","volume":"9","author":"Claro","year":"2020","journal-title":"JRSM Cardiovasc Dis"},{"key":"R60-20260406","doi-asserted-by":"crossref","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","article-title":"Fragile X syndrome.","volume":"3","author":"Hagerman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R61-20260406","doi-asserted-by":"crossref","first-page":"586910","DOI":"10.3389\/fgene.2020.586910","article-title":"Cardiovascular problems in the fragile X premutation.","volume":"11","author":"Tassanakijpanich","year":"2020","journal-title":"Front Genet"},{"key":"R62-20260406","doi-asserted-by":"crossref","first-page":"110775","DOI":"10.1016\/j.cellsig.2023.110775","article-title":"STNM1 in human cancers: role, function and potential therapy sensitizer.","volume":"109","author":"Liu","year":"2023","journal-title":"Cell Signal"},{"issue":"3 Pt 2","key":"R63-20260406","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jacasi.2025.01.013","article-title":"Single-cell transcriptomics identified fibrosis-activated valve interstitial cells involved in functional tricuspid regurgitation.","volume":"5","author":"Zhao","year":"2025","journal-title":"JACC Asia"},{"key":"R64-20260406","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.123.065143","article-title":"Directed differentiation of human induced pluripotent stem cells to heart valve cells.","volume":"149","author":"Cai","year":"2024","journal-title":"Circulation"},{"key":"R65-20260406","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/ATVBAHA.122.318314","article-title":"Cellular landscapes of nondiseased human cardiac valves from end-stage heart failure-explanted heart.","volume":"42","author":"Shu","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R66-20260406","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s10020-025-01220-7","article-title":"STMN1\u2013IGFBP5 axis induces senescence and extracellular matrix degradation in nucleus pulposus cells: in vivo and in vitro insights.","volume":"31","author":"Li","year":"2025","journal-title":"Mol Med"},{"issue":"Suppl 1","key":"R67-20260406","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2024-208205","article-title":"Loss of microtubule protein stathmin-1 impairs autophagy in hematopoietic stem cells.","volume":"144","author":"Chiquetto Paracatu","year":"2024","journal-title":"Blood"},{"key":"R68-20260406","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1534\/genetics.111.131482","article-title":"Cardiomyopathy is associated with ribosomal protein gene haplo-insufficiency in drosophila melanogaster.","volume":"189","author":"Casad","year":"2011","journal-title":"Genetics"},{"key":"R69-20260406","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41401-020-0473-8","article-title":"Matrine attenuates pathological cardiac fibrosis via RPS5\/p38 in mice.","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"R70-20260406","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1007\/s12035-023-03706-z","article-title":"Polyphenols targeting MAP kinase signaling pathway in neurological diseases: understanding molecular mechanisms and therapeutic targets.","volume":"61","author":"Islam","year":"2023","journal-title":"Mol Neurobiol"},{"key":"R71-20260406","doi-asserted-by":"crossref","first-page":"582949","DOI":"10.3389\/fcvm.2020.582949","article-title":"The genetic dissection of Ace2 expression variation in the heart of murine genetic reference population.","volume":"7","author":"Xu","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"R72-20260406","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","article-title":"MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.","volume":"115","author":"Muslin","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"R73-20260406","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/biomedicines12030695","article-title":"APOE gene variation\u2019s impact on cardiovascular health: a case-control study.","volume":"12","author":"Ismail","year":"2024","journal-title":"Biomedicines"},{"key":"R74-20260406","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/01.CIR.0000097560.96431.3E","article-title":"Association between apolipoprotein E alleles and calcific valvular heart disease.","volume":"108","author":"Novaro","year":"2003","journal-title":"Circulation"},{"key":"R75-20260406","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s44161-024-00510-3","article-title":"APOE-NOTCH axis governs elastogenesis during human cardiac valve remodeling.","volume":"3","author":"Liu","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"R76-20260406","doi-asserted-by":"crossref","first-page":"32833","DOI":"10.18632\/oncotarget.15834","article-title":"KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.","volume":"8","author":"Stelma","year":"2017","journal-title":"Oncotarget"},{"key":"R77-20260406","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jare.2020.07.005","article-title":"Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-\u03baB, a link between inflammation and mineralization.","volume":"27","author":"\u00c9va Sikura","year":"2021","journal-title":"J Adv Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:01:37Z","timestamp":1775484097000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":74,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048210","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"2025-09-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}